Accord Logo

Intended for UK patients and members of the public

Co-Codamol Tablets

Active Ingredients

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 15/500mg Film-coated Tablets

PL Number:
0142/0921
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Variation description:

    • Update to SPC section 4.4 and PIL in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871). 

    • Update to PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283). 

    • Additional update to SPC section 4.2 for 15/500mg strength only to correct strength from ‘500mg/15mg’ to ‘15mg/500mg’ in the renal insufficiency table. 

    • Amends to the PIL in line with the latest QRD template (Version 10.3), and correction of ‘cinacelet’ to ‘cinacalcet’.

    SmPC sections updated- 4.2, 4.4 and 10

  • Variation description:

    • Update to SPC section 4.4 and PIL in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871). 

    • Update to PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283). 

    • Additional update to SPC section 4.2 for 15/500mg strength only to correct strength from ‘500mg/15mg’ to ‘15mg/500mg’ in the renal insufficiency table. 

    • Amends to the PIL in line with the latest QRD template (Version 10.3), and correction of ‘cinacelet’ to ‘cinacalcet’.

    PIL sections updated- Heading, Introduction, 2, 3, 4 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 15 mg/500 mg Effervescent Tablets

PL Number:
0142/1259
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 30/500mg Tablets

PL Number:
0142/1308
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update: To update SmPC sections 4.4 and 5.1 of the SmPC in line with the reference product, Solpadol 30mg/500mg Caplets. Consequently, the PIL has been updated. Additionally, section 4.8 of the SmPC and the leaflet have editorial updates and updates in line with MedDRA and to align the pharmacotherapeutical group naming in section 5.1 of the SmPC with the WHO ATC Index.

    SmPC Sections updated: 4.4, 4.8, 5.1 and 10.

  • Description of update: To update SmPC sections 4.4 and 5.1 of the SmPC in line with the reference product, Solpadol 30mg/500mg Caplets. Consequently, the PIL has been updated. Additionally, section 4.8 of the SmPC and the leaflet have editorial updates and updates in line with MedDRA and to align the pharmacotherapeutical group naming in section 5.1 of the SmPC with the WHO ATC Index.

    PIL sections updated: 2, 3, 4, and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 30 mg/500 mg Effervescent Tablets

PL Number:
0142/1260
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Discontinued Other versions of this medicine may still be available. Information for reference purposes.

Co-codamol 60/1000mg Film-coated Tablets

PL Number:
0142/0923
MA Holder:
Accord-UK Ltd
Product Classification:
POM
Product Status:
Discontinued

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 8/500mg Tablets

PL Number:
20075/0702
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • Description of update: To update section 4.5 of the SPC to bring in line with the Reference product Co-codamol 8/500 Tablets (PL 17780/0510; MAH: Zentiva Pharma UK Limited) dated 16th June 2023.

    SmPC Sections updated: 4.5 & 10.

  • Variation Description:

    • 1. To update section 4.4 of the SmPC and PIL section 2 to bring in line with the recommendations following MHRA review of myasthenia gravis (SA 19083871).

    • 2. To update section 2 of the PIL in line with the recommendations following MHRA review of CNS depressants (SA 18643283).

    • The PIL has also been updated to align with the latest QRD template (Version 10.3, 09/2022) as well as the correction of grammar and spelling.

    PIL sections updated- 2, 3, 5 and 6.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 8mg/500mg effervescent tablets

PL Number:
0142/1258
MA Holder:
Accord-UK Ltd
Product Classification:
P
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol 8mg/500mg Effervescent Tablets

PL Number:
20075/0516
MA Holder:
Accord Healthcare Limited
Product Classification:
POM
Product Status:
Active

Product Documentation

  • To update sections 4.2, 4.3, 4.4, 4.5, 4.6, 4.8, 4.9, 5.1 and 5.2 of the SmPC and PIL in line with the reference product Co-Codamol 8/500mg Capsules (PL 42176/0007; MAH: Lucis Pharma Limited) dated 03/06/2024. In addition, editorial updates have been made to PIL.

     

    SmPC section 6.1 and the PIL have been updated to remove "anhydrous" from two excipients, in line with the 9th edition Pharmeuropa and section 4.4 of the SmPC has been updated with excipient Sodium and Sorbitol to be in line with the PIL.

  • To update sections 4.2, 4.3, 4.4, 4.5, 4.6, 4.8, 4.9, 5.1 and 5.2 of the SmPC and PIL in line with the reference product Co-Codamol 8/500mg Capsules (PL 42176/0007; MAH: Lucis Pharma Limited) dated 03/06/2024. In addition, editorial updates have been made to PIL.

     

    SmPC section 6.1 and the PIL have been updated to remove "anhydrous" from two excipients, in line with the 9th edition Pharmeuropa and section 4.4 of the SmPC has been updated with excipient Sodium and Sorbitol to be in line with the PIL.

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Co-codamol Tablets BP 8/500mg

PL Number:
0142/0197
MA Holder:
Accord-UK Ltd
Product Classification:
P
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

Zipamol plus 8 mg/500 mg Effervescent Tablets

PL Number:
0142/1258
MA Holder:
Accord-UK Ltd
Product Classification:
P
Product Status:
Active

Product Documentation

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at yellowcard.mhra.gov.uk. By reporting side effects, you can help provide more information on the safety of this medicine.

Report a side effect or a product complaint

General FAQs

For any further assistance, please get in touch.

View product information as a: